Apriso FDA Approval History
FDA Approved: Yes (First approved October 31, 2008)
Brand name: Apriso
Generic name: mesalamine
Dosage form: Extended-Release Capsules
Company: Salix Pharmaceuticals, Ltd.
Treatment for: Ulcerative Colitis
Apriso (mesalamine) is a once-daily, locally-acting aminosalicylate indicated for the maintenance of remission of ulcerative colitis (UC) in adults.
Development timeline for Apriso
| Date | Article |
|---|---|
| Nov 3, 2008 | Approval Apriso Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
